Phosphate Glass Fibre Composites for Bone Repair

We investigate high-modulus degradable materials intended to replace metals in biomedical applications.These are typicallycomposites comprising a polylactide(PLA)matrix reinforced with phosphate glass fibres,which provide reinforcementsimilar to E-glass but are entirely degradable in water to produce,principally,calcium phosphate.We have made compositesusing a variety of fibre architectures,from non-woven random mats to unidirectional fibre tapes.Flexural properties in theregion of 30 GPa modulus and 350 MPa strength have been achieved-directly comparable to quoted values for human corticalbone.In collaboration with other groups we have begun to consider the development of foamed systems with structures mimickingcancellous bone and this has shown significant promise.The fibres in these foamed structures provide improved creepresistance and reinforcement of the pore walls.To date the materials have exhibited excellent cellular responses in vitro andfurther studies are due to include consideration of the surface character of the materials and the influence of this on cell interaction,both with the composites and the glass fibres themselves,which show promise as a standalone porous scaffold.     

A Novel Injectable Borate Bioactive Glass Cement as an Antibiotic Delivery Vehicle for Treating Osteomyelitis

Background

A novel injectable cement composed of chitosan-bonded borate bioactive glass (BG) particles was evaluated as a carrier for local delivery of vancomycin in the treatment of osteomyelitis in a rabbit tibial model.

Materials and Methods

The setting time, injectability, and compressive strength of the borate BG cement, and the release profile of vancomycin from the cement were measured in vitro. The capacity of the vancomycin-loaded BG cement to eradicate methicillin-resistant Staphylococcus aureus (MRSA)-induced osteomyelitis in rabbit tibiae in vivo was evaluated and compared with that for a vancomycin-loaded calcium sulfate (CS) cement and for intravenous injection of vancomycin.

Results

The BG cement had an injectability of >90% during the first 3 minutes after mixing, hardened within 30 minutes and, after hardening, had a compressive strength of 18±2 MPa. Vancomycin was released from the BG cement into phosphate-buffered saline for up to 36 days, and the cumulative amount of vancomycin released was 86% of the amount initially loaded into the cement. In comparison, vancomycin was released from the CS cement for up 28 days and the cumulative amount released was 89%. Two months post-surgery, radiography and microbiological tests showed that the BG and CS cements had a better ability to eradicate osteomyelitis when compared to intravenous injection of vancomycin, but there was no significant difference between the BG and CS cements in eradicating the infection. Histological examination showed that the BG cement was biocompatible and had a good capacity for regenerating bone in the tibial defects.

Conclusions

These results indicate that borate BG cement is a promising material both as an injectable carrier for vancomycin in the eradication of osteomyelitis and as an osteoconductive matrix to regenerate bone after the infection is cured.     

Novel Mesoporous Hydroxyapatite/Chitosan Composite for Bone Repair

The objective of the present investigation was to evaluate the osteogenic properties of mesoporous Hydroxyapatite/Chitosan (HA/CS) composite in vitro and in vivo.HA/CS composite was successfully prepared and synthesized using a freeze-drying method,and then characterized by Scanning Electron Microscope (SEM).Results show that the mesoporous HA/CS composite presents high surface area and porosity.The effects of mesoporous HA/CS on early adhesion,proliferation and differentiation of osteoblast cells in vitro were measured.MTT cytotoxicity test and cell adhesion test show that the composite has good biocompatibility and promotes cell viability and proliferation.In vitro tests show that osteoblast-like cells on the composite surfaces are able to adhere,proliferate,and migrate through the pores.These cells maintained similar expression levels of osteoblastic-associated markers namely Collagen type Ⅰ (COL-I),Bone Morphogenetic Protein 2(BMP-2).Histologic analysis and radiological analysis in vivo also prove that mesoporous HA/CS composite can be used to repair bone defect as a new kind of bone grafting materials.     

自固化磷酸钙人工骨复合骨形成蛋白在牙槽骨缺损修复中的应用

目的：探讨自固化磷酸钙人工骨（autosolidification calcium phosphate cement,ACPC）复合骨形成蛋白（bone morphogenetic protein,BMP）对牙槽骨缺损修复的生物学作用。方法：将ACPC/BMP即刻植入拔牙术后患者牙槽创口,随访24周,通过临床检查和CCD数字化摄片观察牙槽骨缺损修复情况。结果：实验位点无炎症、过敏和毒性反应发生,实验组患者牙槽嵴骨量吸收较空白对照组少,外形维持较好。结论：BMP/ACPC复合骨兼具骨的引导性和诱导性,可促进新骨沉积钙化,即刻植入拔牙创利于增加牙槽骨量,维持牙槽外形,但材料降解性存在不足。     

新型多孔生物活性玻璃修复羊腔隙性骨缺损的实验研究

目的:评价新型多孔生物活性玻璃修复羊腔隙性骨缺损的能力.方法:12只成年绵羊L3-L5,共36个椎体均建立8mm× 15mm腔隙性骨缺损模型,实验组为Macro Porous Putty(MPS)和Injectable Putty(INJ),对照组为Nova Bone Putty(NBP).按照随机区组设计,随机分配每只羊的三个椎体缺损分别填充NBP、MPS、INJ材料.每种材料均填充12个椎体.术后6周、12周取材,通过术后一般状况、标本大体观察、X线平片以及组织病理学结果评价新型多孔生物活性玻璃的成骨作用.结果:①术后各组动物进食及粪便均正常,对外界刺激反应性良好.术后切口均一期愈合.②大体观察未发现缺损处有异常纤维组织包块及材料漏出.③术后6周和12周,MPS组和INJ组Lane-Sandhu X射线评分大于NBP组(P＜0.05).④组织学切片VG染色结果显示,术后6周和12周,MPS组和INJ组新生骨量多于NBP组(P＜0.05).MPS组和INJ组成骨性能相当(P＞0.05).术后12周和术后6周比较,NBP、MPS、INJ三种材料新生骨量均明显增多(P＜0.01).结论:新型多孔生物活性玻璃材料MPS和INJ具有可靠的骨缺损修复能力,比传统的NBP材料成骨能力更佳,具有良好的应用前景.     

具有中空贯通管结构的磷酸钙骨水泥的制备研究

目前,磷酸钙骨水泥因其具有优良的生物性能已被广泛用于骨组织工程,但它自固化后只是形成具有微孔和封闭气孔的致密块体,其孔径尺寸和连通性仍远达不到骨组织工程的最佳要求.本研究采用α-TCP为原料,以过氧化氢作为发泡剂,使用模具插针法制得一种具有大孔径和中空管的多孔磷酸钙骨水泥材料.孔径达到900μm,孔隙率为50.67%,抗折强度达到5.84MPa.通过扫描电镜照片观察和分析微观结构.结果表明,通过这种方法可以制得具有理想孔径尺寸和连通性的多孔磷酸钙骨水泥,可以说,这为制备用于骨组织工程的多孔磷酸钙骨水泥创造了一种新的方法.     

Novel P-Solubilizers from Calcium Bound Phosphate Rich Pine Forest of Lower Himalaya

Phosphorus, an essential element for life, is continuously depleting from soils and thus demands sustainable management particularly in agriculture and forestry. Inorganic P constitutes the major proportion as tricalcium phosphate in soils of lower Himalayan region of Pakistan. We sampled these soils and screened for P-solubilizing microbes. A range of culturable microbial community (bacteria and fungi) was isolated and molecularly characterized which make the P available from mineral phosphates. There was an increase in abundance of phosphate solubilizing bacteria (PSB) at a 6-inch depth of the pine rhizosphere compared to the surface soil samples. Moreover, the isolates from lower Himalaya have higher abundance and better efficiency to solubilize the inorganic P than the ones from non-Himalaya. Most likely the P-solubilization done by our P-solubilizing microbes is via acidification as we observed the decrease in pH of the medium of microbial growth. Furthermore, the majority of isolated PSB belong to gammaproteobacterial class of Gram negative bacteria. Most interestingly, 13% of our isolated PSB were psychrotolerant (physiologically active at cold environment, i.e., 4°C) and able to solubilize inorganic P as efficiently as at ambient temperature. This study is unique in reporting the P-solubilizing microbes, particularly the psychrotolerant bacterial strains, of Lower Himalaya. Therefore the isolated bacterial and fungal strains have potential and may serve as biofertilizers in the region to increase the P availability in soils.     

A Novel Controlled-Release System for Antibacterial Enzyme Lysostaphin Delivery Using Hydroxyapatite/Chitosan Composite Bone Cement

In this work, a lysostaphin-loaded, control-released, self-setting and injectable porous bone cement with efficient protein delivery was prepared by a novel setting method using hydroxyapatite/chitosan (HA/CS) composite scaffold. The cement samples were made through cementitious reactions by mixing solid powder, a mixture of HA/CS composite particles, lysostaphin, Ca(OH)₂, CaCO₃ and NaHCO₃, with setting liquid containing citric acid, acetic acid, NaH₂PO₄, CaCl₂ and poloxamer. The setting parameters of the cement samples were determined. The results showed that the final setting time was 96.6±5.2 min and the pH value increased from approximately 6.2 to nearly 10 during the setting process and the porosity was 34% at the end. And the microstructure and composition were detected by scanning electron microscopy (SEM), x-ray diffraction and Fourier transform-infrared spectroscopy. For the release behavior of lysostaphin loaded in the cement sample, the in vitro cement extract experiment indicated that about 94.2±10.9% of the loaded protein was released before day 8 and the in vivo Qdot 625 fluorescence tracking experiment showed that the loaded protein released slower than the free one. Then the biocompatibility of the cement samples was evaluated using the methylthiazol tetrazolium assay, SEM and hematoxylin-eosin staining, which suggested good biocompatibility of cement samples with MC 3T3-E1 cells and subcutaneous tissues of mice. Finally the antibacterial activity assay indicated that the loaded lysostaphin had good release ability and strong antibacterial enzymatic activity against methicillin-resistant Staphylococcus aureus. Collectively, all the results suggested that the lysostaphin-loaded self-setting injectable porous bone cement released the protein in a controlled and effective way and the protein activity was well retained during the setting and releasing process. Thus this bone cement can be potentially applied as a combination of artificial bone substitute and controlled-release system for delivery of lysostaphin to treat bone defects and infections.     

3D Bio-Plotted Composite Scaffold Made of Collagen Treated Hydroxyapatite-Tricalciumphosphate for Rabbit Tibia Bone Regeneration

Biphasic calcium phosphate scaffolds with 20/80 HA/TCP ratio were fabricated using the 3D-Bioplotting system to heal critical size defects in rabbit tibia bone. Four different architectures were printed in a layer by layer fashion with lay down patterns viz. (a) 0°– 90°, (b) 0°– 45°– 90°– 135°, (c) 0°–108°– 216° and (d) 0°– 60°– 120°. After high-temperature sintering scaffolds were coated with collagen and were further characterized by (FTIR) Fourier Transform Infrared Spectroscopy, (SEM) Scanning Electron Microscopy, (XRD) X-Ray diffraction, Porosity analysis and Mechanical testing. Scaffold samples were tested for its ability to induce cytotoxicity in Balb/c 3T3 cells at in vitro condition using elution method. Skin sensitization potential of scaffolds was evaluated in male guinea pigs using guinea pig maximization test (GPMT). Further, scaffolds were implanted in eight rabbit tibia bones and biocompatibility and histological evaluations were carried out after 4 and 8 weeks implantation periods. In-vitro results include bonding, surface morphology, phases, porosity, mechanical strength and Cytotoxicity. In-vivo results include sensitization, capsule formation, inflammation, presence of polymorphonuclear cells, giant cells, plasma cells, X-Rays and degradation of the material. It was concluded that HA/TCP/Collagen scaffold with 0°– 45°– 90°– 135° architecture exhibits the most excellent properties in healing critical size bone defects in rabbits.     

Injectable Biocomposites for Bone Healing in Rabbit Femoral Condyle Defects

A novel biomimetic bone scaffold was successfully prepared in this study, which was composed of calcium sulfate hemihydrate (CSH), collagen and nano-hydroxyapatite (nHAC). CSH/nHAC was prepared and observed with scanning electron microscope and rhBMP-2 was introduced into CSH/nHAC. The released protein content from the scaffold was detected using high performance liquid chromatography at predetermined time interval. In vivo bone formation capacity was investigated by means of implanting the scaffolds with rhBMP-2 or without rhBMP-2 respectively into a critical size defect model in the femoral condyle of rabbit. The releasing character of rhBMP-2 was that an initial burst release (37.5%) was observed in the first day, followed by a sustained release and reached 100% at the end of day 20. The CSH/nHAC showed a gradual decrease in degradation with the content of nHAC increase. The results of X-rays, Micro CT and histological observation indicated that more new bone was formed in rhBMP-2 group. The results implied that this new injectable bone scaffold should be very promising for bone repair and has a great potential in bone tissue engineering.     

丝素蛋白/羟基磷灰石复合物对磷酸钙骨水泥性能的影响

目的：磷酸钙骨水泥（Calcium phosphate cement,CPC）以其诸多优点正得到了越来越多的应用,但其较差的力学性能表现也限制了它的使用范围。本研究目的在于改善磷酸钙骨水泥的力学性能,同时评估改性后的磷酸钙骨水泥的其他性能。方法：通过丝素蛋白（Silk fibroin,SF）的矿化自组装方法制备丝素蛋白／羟基磷灰石复合物（silk fibroin/hydroxyapitite composite, SF/HA）。按照1％、2％、3％、4％的质量分数加入磷酸钙骨水泥中,与磷酸钙骨水泥组对比。比较内容包括力学强度、抗渍散性能及细胞毒性。结果：以丝素蛋白溶液为液相组的磷酸钙骨水泥强度大约为35MPa。随后随着添加丝素蛋白／羟基磷灰石复合物的质量分数从1％增至3％,磷酸钙骨水泥的强度逐渐增加（P〈0．05）,最高约至45MPa。而当丝素蛋白／羟基磷灰石的质量分数达到4％时,磷酸钙骨水泥的强度较质量分数3％组小幅度下降至43MPa（P〈0．05）。以丝素蛋白溶液作为液相时,磷酸钙骨水泥的抗溃散能力也得到了加强。在MTT法测定细胞活力的对照实验中,无论是加入丝素蛋白溶液或丝素蛋白／羟基磷灰石复合物,都未观察到细胞毒性。结论：在磷酸钙骨水泥中加入3％质量分数的丝素蛋白／羟基磷灰石复合物,能显著提高磷酸钙骨水泥的抗压强度。而丝素蛋白溶液作为液相可改善磷酸钙骨水泥的抗溃散能力。同时,丝素蛋白和丝素蛋白／羟基磷灰石复合物都不表现出细胞毒性。更理想的力学强度和更强的抗溃散能力,大大扩展了磷酸钙骨水泥的应用范围。     

纤维蛋白凝胶联合磷酸钙骨水泥的理化性能及生物相容性

目的:探讨纤维蛋白凝胶联合磷酸钙骨水泥的理化性能及生物相容性.方法:将磷酸钙骨水泥作为对照组,纤维蛋白凝胶联合磷配钙骨水泥作为研究组,通过测定两组复合物抗压强度极限、抗弯强度极限、电镜结构以及固化体相组成,初步分析纤维蛋白凝胶联合磷酸钙骨水泥复合材料的理化性能及生物相容性.结果:与对照组抗压强度极限、抗弯强度极限比较,研究组抗压强度极限、抗弯强度极限明显增加,差异显著,有统计学意义(P＜0.05),扫描电镜显示研究组微孔数少于对照组,纤维分散较好.X线衍射观察在31b和35b之间均可见衍射峰,并且与对照组相比较,研究组特征衍射峰强度相对高,羟基磷灰石相比例增加.结论:纤维蛋白凝胶的加入提高了骨水泥强度,加速骨水泥向羟基磷灰石转化,是比较好的骨移植替代材料.     

碳纤维/碳纳米管增强磷酸钙生物复合材料的血液相容性研究

目的：探讨以碳长纤维模拟骨组织中的胶原纤维束,碳纳米管弥散分布在骨水泥基质中所制备的仿生复合材料的血液相容性。方法：采用血小板静态浸渍黏附、聚集实验法,通过扫描电镜（SEM）观察复合材料表面、粗糙断面及气孔内的血栓形成情况,对其血液相容性进行研究。结果：以两种碳材料为增强相制备的复合材料与血液接触后,在材料光滑的表面、粗糙的断面及气孔内、以及碳纤维与碳纳米管的表面,由于纤维蛋白原的吸附量较少使血小板难以黏附、聚集,因此,在材料表面未能形成白血栓。结论：以碳纤维和碳纳米管为增强相制备的骨水泥生物复合材料具有良好的血液相容性。     

Wnt Signaling is Essential for Bone Regeneration

This article has no abstract.     

A Novel Healing Filament in Ciliate Regeneration

The interphase cells of the hypotrich ciliate Paraurostyla weissei possess a complex fibrillar system surrounding basal bodies in the compound ciliary assemblages, cirri and membranelles. During replacement of the ciliature at cell division, transient filaments precede and accompany the development of ciliary primordia and participate in the formation of the fission furrow. Both fibrillar systems are recognized by monoclonal antibody FXXXIX 12G9. We studied regeneration of cellular fragments after transection employing the mAb 12G9 and found a new cytoskeletal structure involved in healing of the excisional wound. The healing filament is formed at the wound edge, distally and in connection with the bases of cirri closest to the wound. It is visible 5 min after transection. Concomitant with development of new ciliary primordia, the healing filament shrinks and finally disappears together with other transient fibers formed in this process. Ultrastructural analysis of immunolabeled regenerating cells revealed that structures recognized by mAb 12G9 contain fine filaments whose packing and arrangement depends on accompanying cytoplasmic elements and the developmental status of a fragment. Assembly of the healing fiber does not depend on microtubules and microfilaments since it develops in cellular fragments exposed to cold, nocodazole, and Cytochalasin D. On Western blots of whole cell and cytoskeletal extracts of P. weissei the 12G9 antibody identified one protein band whose molecular weight corresponds to 60 kDa.     

自固化磷酸钙人工骨修复小儿局部骨缺损的临床应用

目的：研讨自固化磷酸钙人工骨（Calcium Phosphate Cement,CPC)填充修复小儿局部骨缺损的临床意义,方法：选用CPC修复小儿骨缺损18例,年龄最小8个月,最大12岁,平均8岁,骨缺损部位：肱骨9例,胫骨6例,胫骨3例,病因,单纯性骨囊肿8例,骨纤维异常增生症5例,动脉瘤样骨囊肿4例,嗜酸性肉芽肿1例,骨缺损大小,最大7cm,最小2cm,平均5cm,CPC填充方式：单纯粉末7例,粉末＋松质骨粒6例,粉末＋条形骨块5例。CPC初步固化时间,最短15分钟,最长30分钟,平均20分钟,随访时间：13－27个月,平均18．5个月。结果：全组18例应用CPC后未见明显局部和全身不良反应。手术前后血PH值钙磷代谢无异常改变。X线片显示：CPC与宿主骨接触紧密,无脱落,术后3个月出现降解,新生骨形成。结论：CPC安全无毒,使用方便,易塑形,生物相容性好,能在体内降解,可以替代自体骨材料在小儿局部骨缺损应用。     

骨诱导无机材料BAM 修复牙种植体周围骨缺损的实验研究

目的:评价骨诱导磷酸钙生物陶瓷(BAMOICPC)与可吸收胶原膜(BME-10X医用胶原膜)在牙种植体周围骨缺损中的修复能力。方法:在兔股骨上植入羟基磷灰石涂层BLB种植体,然后在其侧壁制造高4 mm、宽3 mm、深2 mm的骨缺损。对照组为单纯侧壁骨缺损,实验A组骨缺损区仅覆盖BME-10X膜,B组骨缺损区植入BAMOICPC,C组骨缺损区植入BAMOICPC并加盖BME-10X膜。于术后6个月取带种植体的骨段,通过HE染色和扫描电镜(SEM)分析。结果:对照组骨缺损区种植体表面见纤维包裹,实验A组骨缺损边界区少许骨质移行覆盖,实验B组下半部分缺损区新生骨覆盖。C组新生骨完全覆盖骨缺损区,且较B组硬度高,扫描电镜见与种植体结合更紧密。组织学观察B、C两实验组新生骨均可见比较成熟的哈弗氏管系统。结论:骨诱导磷酸钙生物陶瓷BAMOICPC是一种较理想的骨替代材料,联合运用胶原膜修复种植体周骨缺损效果佳。     

一种稳定且高效的磷酸钙293T细胞转染法

目的:用磷酸钙细胞转染法稳定高效地转染293T细胞.方法:利用磷酸钙转染法将MSCV-GFP质粒导入293T细胞,在混合DNA-CaCl2溶液和2×HBS缓冲液以形成沉淀物时,对混悬方式和时间这两个至关重要的因素进行了调整.并将该法与常用磷酸钙细胞转染法进行了比较.结果:在调整了混悬方式和时间后,得到了85%以上的转染率.在对比实验中,常用磷酸钙细胞转染法得到85%以上转染率所占比率为50%,而利用该文方法比率则为100%.结论:利用此磷酸钙细胞转染法可稳定高效地转染293T细胞.